Loading...
Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial
BACKGROUND: Irritable bowel syndrome (IBS) is common, affecting 10–20% of the adult population worldwide, with many people reporting ongoing symptoms despite first-line therapies. Cognitive behavioural therapy (CBT) is recommended in guidelines for refractory IBS but there is insufficient access to...
Saved in:
| Published in: | Lancet Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier B.V
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7026694/ https://ncbi.nlm.nih.gov/pubmed/31492643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(19)30243-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|